Author profile: Argüelles Arias, Federico
Data
Name | Argüelles Arias, Federico |
Department | Medicina |
Knowledge area | Medicina |
Professional category | Profesor Contratado Doctor (Plaza Vinc.) |
Request | |
![]() ![]() ![]() ![]() ![]() ![]() |
Statistics
-
Items
13
-
Visits
1721
-
Downloads
3029
Publications |
---|
Article
![]() Native Chilean Berries Preservation and In Vitro Studies of a Polyphenol Highly Antioxidant Extract from Maqui as a Potential Agent against Inflammatory Diseases
(MDPI, 2021-05-01)
The best conservation method for native Chilean berries has been investigated in combination with an implemented large-scale ... |
PhD Thesis
![]() Monitorización de niveles de Infliximab y anticuerpos Anti-Infliximab en pacientes con enfermedad inflamatoria intestinal en práctica clínica
(2021-03-24)
Introducción Infliximab (IFX) es un fármaco anti-TNF que consigue una buena tasa de respuesta y remisión en muchos pacientes ... |
PhD Thesis
![]() Evaluación de la variabilidad interobservador de los scores endoscópicos que valoran la actividad de la enfermedad en pacientes con colitis ulcerosa
(2020-05-27)
Objetivos: el objetivo principal del estudio fue evaluar la variabilidad interobservador para el Índice de Mayo Endoscópico ... |
Article
![]() Polyphenolic Maqui Extract as a Potential Nutraceutical to Treat TNBS-Induced Crohn' s Disease by the Regulation of Antioxidant and Anti-Inflammatory Pathways
(MDPI, 2020-01-01)
Nutraceuticals include a wide variety of bioactive compounds, such as polyphenols, which have been highlighted for their ... |
Article
![]() Polymeric nanoparticles for drug delivery: Recent developments and future prospects
(Multidisciplinary Digital Publishing Institute (MDPI), 2020-01-01)
The complexity of some diseases—as well as the inherent toxicity of certain drugs—has led to an increasing interest in the ... |
Article
![]() Long-term follow up after switching from original infliximab to an infliximab biosimilar: real-world data
(Original Research, 2019-01-01)
Background: Several studies have reported positive efficacy outcomes for patients with inflammatory bowel disease treated ... |
PhD Thesis
![]() Valoración de la eficacia de Infliximab biosimilar (CT-P13, remsima®) frente al Infliiximab original (Remicade®) en pacientes con enfermedad inflamatoria intestinal.
(2018-05-16)
Introducción: las terapias biológicas, particularmente agentes anti-TNF alfa, han revolucionado el enfoque terapéutico de ... |
Article
![]() Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: 12 months results
(Lippincott Williams & Wilkins, 2017-01-01)
Background: Biological agents, such as infliximab, have transformed the outcomes of patients with immune-mediated inflammatory ... |
PhD Thesis
![]() Estudio comparativo, prospectivo y randomizado de tres preparaciones para el estudio del colon mediante cápsula endoscópica de colón
(2016-12-05)
Introducción y objetivos. El cáncer colorrectal (CCR) representa en conjunto el 10% de todos los tumores a nivel mundial. ... |
Article |
Article |
Article |
Article
![]() Accidental intrarectal administration of alcohol enema induces proctocolitis and fecal incontinence
(Georg Thieme, 2001-07-18)
|